Integrated risk-benefit analyses: method development with folic acid as example.
暂无分享,去创建一个
H. V. van Kranen | M. Zeilmaker | C. Rompelberg | J. Verkaik-Kloosterman | J. Hoekstra | H. Verhagen | N. de Jong
暂无分享,去创建一个
H. V. van Kranen | M. Zeilmaker | C. Rompelberg | J. Verkaik-Kloosterman | J. Hoekstra | H. Verhagen | N. de Jong